The global laboratory animal model market is experiencing consistent growth, driven by increasing demand for preclinical research, rising prevalence of chronic diseases, and advancements in biotechnology. The market is projected to expand at a CAGR of 8.1% from 2025 to 2031, reflecting strong demand for animal models in drug discovery, disease research, and biomedical innovation.

Laboratory animal models, including mice, rats, rabbits, and genetically modified organisms, are essential tools in understanding disease mechanisms and evaluating drug safety and efficacy. The increasing complexity of diseases such as cancer, neurological disorders, and cardiovascular conditions has intensified the need for reliable and predictive animal models. Additionally, the rise in pharmaceutical and biotechnology investments is significantly contributing to market growth. Innovations such as CRISPR gene editing and humanized animal models are further enhancing the precision and relevance of these models in modern research.

Key Players in the Laboratory Animal Model Market

The Laboratory Animal Model Market Key Players are actively driving innovation through advanced genetic engineering, strategic partnerships, and expansion of research capabilities. These companies are focused on delivering high-quality, ethically sourced animal models to support global research initiatives.

Some of the prominent Key Players Laboratory Animal Model Market include:

• Charles River Laboratories International, Inc.
• Envigo
• Eurofins Scientific
• genOway
• Hera Biolabs
• JSR Life Sciences, LLC (Crown Bioscience International)
• Ozgene Pty Ltd.
• PerkinElmer (Horizon Discovery Ltd.)
• Taconic Biosciences, Inc.

These companies are leveraging technological advancements and global collaborations to strengthen their market position and address the growing demand for sophisticated animal models.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00025691

Market Drivers and Growth Factors

The laboratory animal model market is primarily driven by the surge in drug discovery and development activities. Pharmaceutical and biotechnology companies rely heavily on animal models to test the safety and efficacy of new drugs before clinical trials. As the global pipeline of new therapeutics expands, the demand for reliable preclinical models continues to rise.

Another significant driver is the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders. These conditions require extensive research to understand disease progression and develop effective treatments. Laboratory animal models play a critical role in this process by enabling researchers to simulate human disease conditions and evaluate therapeutic interventions.

Advancements in biotechnology and personalized medicine are also contributing to market growth. Technologies such as gene editing and transgenic modeling are enabling the development of highly specialized animal models that closely mimic human biology. These innovations are enhancing the accuracy of preclinical studies and accelerating the development of targeted therapies.

North America Laboratory Animal Model Market Insights

North America dominates the global laboratory animal model market and is expected to maintain its leadership position through 2031. The region benefits from a well-established healthcare infrastructure, strong presence of pharmaceutical and biotechnology companies, and significant investments in research and development.

The United States is the largest contributor to the North American market, driven by extensive funding for biomedical research and a robust network of academic and research institutions. Government agencies and private organizations are continuously investing in drug discovery and translational research, creating strong demand for laboratory animal models.

Additionally, North America is at the forefront of adopting advanced technologies such as CRISPR and humanized animal models. These innovations are enabling researchers to conduct more precise and efficient studies, further boosting market growth. The region also has well-defined regulatory frameworks that ensure ethical use of animal models, supporting sustainable market development.

Segmental Analysis

The laboratory animal model market is segmented based on animal type, application, and end user. By animal type, the market includes mice, rats, guinea pigs, rabbits, and others. Among these, mice and rats dominate the market due to their genetic similarity to humans and ease of handling in research settings.

In terms of application, the market is categorized into drug discovery and development, and basic research. Drug discovery and development account for the largest share, as pharmaceutical companies increasingly rely on animal models to validate new therapies.

Based on end users, the market includes pharmaceutical and biotechnology companies, and academic research institutes. Pharmaceutical and biotech companies represent the largest segment due to their extensive involvement in preclinical research and drug development pipelines.

Emerging Trends and Opportunities

The laboratory animal model market is evolving rapidly with the emergence of new trends and technologies. One of the key trends is the development of genetically modified and humanized animal models. These models provide more accurate insights into human diseases, improving the success rate of drug development.

Another significant trend is the growing emphasis on ethical considerations and the reduction of animal testing. Researchers are increasingly exploring alternative methods such as organ-on-a-chip and 3D cell cultures. While these alternatives pose challenges to the market, they also encourage innovation and the development of more refined animal models.

The increasing trend of outsourcing research to contract research organizations (CROs) is also creating new opportunities. CROs specialize in preclinical studies and provide cost-effective solutions for pharmaceutical companies, thereby driving demand for laboratory animal models.

Top Trending Reports:

Animal Care Services Market Analysis, Regional and Competitive Landscape Forecast by 2031

Laboratory Equipment Services Market Opportunities, Forecast, Size, Analysis till 2031

Laboratory Developed Test Market Size Trends & Key Opportunities 2034

About Us

The Insight Partners is a leading global market research and consulting firm that provides actionable insights across various industries, including healthcare, life sciences, and technology. Our reports are designed to help organizations make informed decisions by offering comprehensive market analysis, trends, and forecasts.

Contact Us

The Insight Partners
Email: sales@theinsightpartners.com
Phone: +1-646-491-9876
Website: www.theinsightpartners.com

Also Available in: Korean | German | Japanese | French | Chinese | Italian | Spanish